Genetic alterations of the PIK3CA oncogene in human oral squamous cell carcinoma in an Indian population

被引:11
|
作者
Shah, Sejal [1 ]
Shah, Siddharth [2 ]
Padh, Harish [1 ]
Kalia, Kiran [1 ]
机构
[1] Sardar Patel Univ, BRD Sch Biosci, Vallabh Vidyanagar 388120, Gujarat, India
[2] PS Med Coll, ENT Dept, Karamsad 388325, Gujarat, India
关键词
HIGH-FREQUENCY; MUTATIONS; HEAD; PATHWAY; CANCER; TARGET;
D O I
10.1016/j.oooo.2015.08.003
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective. The phosphatidylinositol 3-kinase (PIK3) genes, which code for heterodimeric lipid kinases, consist of a catalytic subunit, p110a (PIK3CA), which regulates cell proliferation, apoptosis, and metastasis. Recently, a high frequency of somatic mutations was observed in the PIK3CA gene in various cancer types, including oral squamous cell carcinoma (OSCC). This study aimed to determine the frequency of oncogenic hotspot mutations in exons 9 and 20 of the PIK3CA gene and its correlation with the clinical characteristics of OSCC patients in an Indian population. Study Design. We analyzed exons 9 and 20 of the PIK3CA gene using polymerase chain reaction (PCR) and direct genomic sequencing of 50 OSCC primary tumors. Results. We observed two hotspot oncogenic mutations (E542 K, E545 K) in exon 9 and two synonymous mutations (A994 A, T1025 T) in exon 20. Moreover, we identified two single nucleotide polymorphisms (SNPs), rs114587137 (C>T) and rs17849071 (T>G), in intron 9 of the PIK3CA gene. Both oncogenic hotspot mutations were reported primarily in patients with advanced-stage cancer of the buccal mucosa. Conclusions. We have observed a 4% oncogenic mutation frequency of the PIK3CA gene, which plays a minor role in the development of OSCC in an Indian population.
引用
收藏
页码:628 / 635
页数:8
相关论文
共 50 条
  • [41] Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma
    Hayes, Monica Prasad
    Douglas, Wayne
    Ellenson, Lora Hedrick
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 113 (03) : 370 - 373
  • [42] PIK3CA is implicated as an oncogene in ovarian cancer
    Shayesteh, L
    Lu, YL
    Kuo, WL
    Baldocchi, R
    Godfrey, T
    Collins, C
    Pinkel, D
    Powell, B
    Mills, GB
    Gray, JW
    [J]. NATURE GENETICS, 1999, 21 (01) : 99 - 102
  • [43] PIK3CA is implicated as an oncogene in ovarian cancer
    Laleh Shayesteh
    Yiling Lu
    Wen-Lin Kuo
    Russell Baldocchi
    Tony Godfrey
    Colin Collins
    Daniel Pinkel
    Bethan Powell
    Gordon B. Mills
    Joe W. Gray
    [J]. Nature Genetics, 1999, 21 : 99 - 102
  • [44] PIK3CA activating mutation promotes an immune suppressive microenvironment in squamous cell carcinoma
    Nicholson, Benjamin T.
    Guo, Weijie
    Miao, Yuxuan
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [45] Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma
    Akagi, Ichiro
    Miyashita, Masao
    Makino, Hiroshi
    Nomura, Tsutomu
    Hagiwara, Nobutoshi
    Takahashi, Ken
    Cho, Kazumitsu
    Mishima, Takuya
    Ishibashi, Osamu
    Ushijima, Toshikazu
    Takizawa, Toshihiro
    Tajiri, Takashi
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (03) : 767 - 775
  • [46] Genetic alterations of PIK3CA and tumor response in patients with locally advanced cervical squamous cell carcinoma treated with cisplatin-based concurrent chemoradiotherapy
    Wang, Juan
    Chai, Yan-lan
    Wang, Tao
    Liu, Jin-hui
    Dai, Peng-gao
    Liu, Zi
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2015, 98 (03) : 407 - 410
  • [47] KRAS, BRAF, PIK3CA, and human papilloma virus (HPV) status in squamous cell anal carcinoma (SCAC).
    Gardini, Andrea Casadei
    Capelli, Laura
    Ulivi, Paola
    Giannini, Massimo
    Freier, Eva
    Tamberi, Stefano
    Passardi, Alessandro
    Rosetti, Paola
    Calistri, Daniele
    Saragoni, Luca
    Puccetti, Maurizio
    Valgiusti, Martina
    Amadori, Dino
    Frassineti, Giovanni Luca
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [48] Establishment of a human ovarian clear cell carcinoma cell line mutant in PIK3CB but not PIK3CA
    Hoshino, Hitomi
    Inoue, Daisuke
    Shinagawa, Akiko
    Yoshida, Hisato
    Shigeto, Shohei
    Matsuda, Kazuyuki
    Akama, Tomoya O.
    Yoshida, Yoshio
    Kobayashi, Motohiro
    [J]. HUMAN CELL, 2024, 37 (04) : 1184 - 1193
  • [49] PIK3CA mutation in colorectal cancer:: Relationship with genetic and epigenetic alterations
    Nosho, Katsuhiko
    Kawasaki, Takako
    Ohnishi, Mutsuko
    Suemoto, Yuko
    Kirkner, Gregory J.
    Zepf, Dimity
    Yan, Liying
    Longtine, Janina A.
    Fuchs, Charles S.
    Ogino, Shuji
    [J]. NEOPLASIA, 2008, 10 (06): : 534 - 541
  • [50] Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
    Kim, Dong Hyun
    Lim, Seung Taek
    Kim, Hye Ryun
    Kang, Eun Joo
    Ahn, Hee Kyung
    Lee, Yun- Gyoo
    Sun, Der Sheng
    Kwon, Jung Hye
    Lee, Sang-Cheol
    Lee, Hyun Woo
    Kim, Min Kyoung
    Keam, Bhumsuk
    Park, Keon-Uk
    Shin, Seong-Hoon
    Yun, Hwan Jung
    [J]. ORAL ONCOLOGY, 2024, 151